Topamax gets label expansion

|By:, SA News Editor

The FDA approves Topamax (topiramate) for use in adolescents ages 12 to 17. This is the first such clearance for a migraine headache drug for this age group.

Johnson & Johnson's (JNJ) Janssen Pharmaceuticals unit manufactures the product.